187 related articles for article (PubMed ID: 25909884)
21. Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration.
Teixeira-Clerc F; Belot MP; Manin S; Deveaux V; Cadoudal T; Chobert MN; Louvet A; Zimmer A; Tordjmann T; Mallat A; Lotersztajn S
Hepatology; 2010 Sep; 52(3):1046-59. PubMed ID: 20597071
[TBL] [Abstract][Full Text] [Related]
22. Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-α induced hepatocyte apoptosis.
Tao YY; Yan XC; Zhou T; Shen L; Liu ZL; Liu CH
BMC Complement Altern Med; 2014 Nov; 14():449. PubMed ID: 25407538
[TBL] [Abstract][Full Text] [Related]
23. The biliary epithelium gives rise to liver progenitor cells.
Rodrigo-Torres D; Affò S; Coll M; Morales-Ibanez O; Millán C; Blaya D; Alvarez-Guaita A; Rentero C; Lozano JJ; Maestro MA; Solar M; Arroyo V; Caballería J; van Grunsven LA; Enrich C; Ginès P; Bataller R; Sancho-Bru P
Hepatology; 2014 Oct; 60(4):1367-77. PubMed ID: 24700364
[TBL] [Abstract][Full Text] [Related]
24. Effect of perfluorooctane sulphonate-induced Kupffer cell activation on hepatocyte proliferation through the NF-κB/TNF-α/IL-6-dependent pathway.
Han R; Zhang F; Wan C; Liu L; Zhong Q; Ding W
Chemosphere; 2018 Jun; 200():283-294. PubMed ID: 29494909
[TBL] [Abstract][Full Text] [Related]
25. Hsp72 protects against liver injury via attenuation of hepatocellular death, oxidative stress, and JNK signaling.
Levada K; Guldiken N; Zhang X; Vella G; Mo FR; James LP; Haybaeck J; Kessler SM; Kiemer AK; Ott T; Hartmann D; Hüser N; Ziol M; Trautwein C; Strnad P
J Hepatol; 2018 May; 68(5):996-1005. PubMed ID: 29331340
[TBL] [Abstract][Full Text] [Related]
26. STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway.
Conde de la Rosa L; Garcia-Ruiz C; Vallejo C; Baulies A; Nuñez S; Monte MJ; Marin JJG; Baila-Rueda L; Cenarro A; Civeira F; Fuster J; Garcia-Valdecasas JC; Ferrer J; Karin M; Ribas V; Fernandez-Checa JC
J Hepatol; 2021 Jun; 74(6):1429-1441. PubMed ID: 33515644
[TBL] [Abstract][Full Text] [Related]
27. The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation.
Chen CC; Kim KH; Lau LF
Oncogene; 2016 Mar; 35(10):1314-23. PubMed ID: 26028023
[TBL] [Abstract][Full Text] [Related]
28. The strength of the Fas ligand signal determines whether hepatocytes act as type 1 or type 2 cells in murine livers.
Schüngel S; Buitrago-Molina LE; Nalapareddy Pd; Lebofsky M; Manns MP; Jaeschke H; Gross A; Vogel A
Hepatology; 2009 Nov; 50(5):1558-66. PubMed ID: 19711425
[TBL] [Abstract][Full Text] [Related]
29. IFN-γ inhibits liver progenitor cell proliferation in HBV-infected patients and in 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet-fed mice.
Weng HL; Feng DC; Radaeva S; Kong XN; Wang L; Liu Y; Li Q; Shen H; Gao YP; Müllenbach R; Munker S; Huang T; Chen JL; Zimmer V; Lammert F; Mertens PR; Cai WM; Dooley S; Gao B
J Hepatol; 2013 Oct; 59(4):738-45. PubMed ID: 23747755
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice.
Louis H; Van Laethem JL; Wu W; Quertinmont E; Degraef C; Van den Berg K; Demols A; Goldman M; Le Moine O; Geerts A; Devière J
Hepatology; 1998 Dec; 28(6):1607-15. PubMed ID: 9828225
[TBL] [Abstract][Full Text] [Related]
31. The BH3-only protein BID impairs the p38-mediated stress response and promotes hepatocarcinogenesis during chronic liver injury in mice.
Orlik J; Schüngel S; Buitrago-Molina LE; Marhenke S; Geffers R; Endig J; Lobschat K; Rössler S; Goeppert B; Manns MP; Gross A; Vogel A
Hepatology; 2015 Sep; 62(3):816-28. PubMed ID: 25951810
[TBL] [Abstract][Full Text] [Related]
32. Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells.
Rivadeneira DB; Mayhew CN; Thangavel C; Sotillo E; Reed CA; Graña X; Knudsen ES
Gastroenterology; 2010 May; 138(5):1920-30. PubMed ID: 20100483
[TBL] [Abstract][Full Text] [Related]
33. Deletion of Bid impedes cell proliferation and hepatic carcinogenesis.
Bai L; Ni HM; Chen X; DiFrancesca D; Yin XM
Am J Pathol; 2005 May; 166(5):1523-32. PubMed ID: 15855651
[TBL] [Abstract][Full Text] [Related]
34. Caspase-3 suppresses diethylnitrosamine-induced hepatocyte death, compensatory proliferation and hepatocarcinogenesis through inhibiting p38 activation.
Shang N; Bank T; Ding X; Breslin P; Li J; Shi B; Qiu W
Cell Death Dis; 2018 May; 9(5):558. PubMed ID: 29752472
[TBL] [Abstract][Full Text] [Related]
35. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
36. Bid agonist regulates murine hepatocyte proliferation by controlling endoplasmic reticulum calcium homeostasis.
Ni HM; Baty CJ; Li N; Ding WX; Gao W; Li M; Chen X; Ma J; Michalopoulos GK; Yin XM
Hepatology; 2010 Jul; 52(1):338-48. PubMed ID: 20578150
[TBL] [Abstract][Full Text] [Related]
37. Loss of Gab1 adaptor protein in hepatocytes aggravates experimental liver fibrosis in mice.
Kizu T; Yoshida Y; Furuta K; Ogura S; Egawa M; Chatani N; Hamano M; Takemura T; Ezaki H; Kamada Y; Nishida K; Nakaoka Y; Kiso S; Takehara T
Am J Physiol Gastrointest Liver Physiol; 2015 Apr; 308(7):G613-24. PubMed ID: 25617348
[TBL] [Abstract][Full Text] [Related]
38. Berberine and S allyl cysteine mediated amelioration of DEN+CCl4 induced hepatocarcinoma.
Sengupta D; Chowdhury KD; Sarkar A; Paul S; Sadhukhan GC
Biochim Biophys Acta; 2014 Jan; 1840(1):219-44. PubMed ID: 23999088
[TBL] [Abstract][Full Text] [Related]
39. Gankyrin Promotes Tumor-Suppressor Protein Degradation to Drive Hepatocyte Proliferation.
D'Souza AM; Jiang Y; Cast A; Valanejad L; Wright M; Lewis K; Kumbaji M; Shah S; Smithrud D; Karns R; Shin S; Timchenko N
Cell Mol Gastroenterol Hepatol; 2018; 6(3):239-255. PubMed ID: 30109252
[TBL] [Abstract][Full Text] [Related]
40. Loss of Ufl1/Ufbp1 in hepatocytes promotes liver pathological damage and carcinogenesis through activating mTOR signaling.
Chen F; Sheng L; Zhou T; Yan L; Loveless R; Li H; Teng Y; Cai Y
J Exp Clin Cancer Res; 2023 May; 42(1):110. PubMed ID: 37131258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
